Brodalumab: Efficacy, safety, and survival in mid-term (52 weeks) on real clinical practice in Andalucia, Spain

  1. Galan-Gutierrez, M.
  2. Font-Ugalde, P.
  3. Padilla, L.
  4. Hernandez-Montoya, C.
  5. Godoy, D.
  6. Armario-Hita, J.C.
  7. Ruiz-Villaverde, R.
Aldizkaria:
International Journal of Dermatology

ISSN: 1365-4632,  0011-9059

Argitalpen urtea: 2023

Alea: 62

Zenbakia: 5

Orrialdeak: 700-706

Mota: Artikulua

DOI: 10.1111/IJD.16527 GOOGLE SCHOLAR
Datuen iturria: Scopus